Table 1. Clinical characteristics of patients (n = 30).
| Variables | Number | (range, %) | |
|---|---|---|---|
| Age (year) | 65 | (49–89) | |
| BMI (kg/m2) | 26.2 | (20.8–37.6) | |
| 18.5 to 25 | 15 | (50) | |
| 25 to 30 | 8 | (26.7) | |
| 30 to 35 | 3 | (10) | |
| 35 to 40 | 2 | (6.7) | |
| Unknown | 2 | (6.7) | |
| Menopausal state | Premenauposal | 4 | (13.3) |
| Postmenauposal | 24 | (80) | |
| Unknown | 2 | (6.7) | |
| Type | Ductal invasive | 27 | (90) |
| Lobular invasive | 1 | (3.3) | |
| Dual invasive | 2 | (6.7) | |
| Lymph node involvement | Negative | 17 | (56.7) |
| Positive | 13 | (43.3) | |
| Histologic grade | Grade 1 | 5 | (16.7) |
| Grade 1–2 | 2 | (6.7) | |
| Grade 2 | 13 | (43.3) | |
| Grade 3 | 10 | (33.3) | |
| ER expression | Negative | 1 | (3.3) |
| Positive | 29 | (96.7) | |
| PR expression | Negative | 5 | (16.7) |
| Positive | 25 | (83.3) | |
| HER-2 expression | No overexpression | 28 | (93.3) |
| Overexpression | 2 | (6.7) |
BMI = Body Mass Index; ER = Estrogen Receptor; PR = Progesterone Receptor; HER = Human
epidermal growth factor receptor